Key result
Pacemaker lead thrombosis complicated by endocarditis causes fatal sepsis in an IV drug user.
Why the study?
Patients with pacemakers are at risk of developing pacemaker lead thrombosis and endocarditis, especially with additional risk factors such as intravenous drug abuse.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
Alerts to lead thrombosis/endocarditis risk in pacemaker patients with IV drug use; leaves open optimal prevention strategies.
We report a 30-year-old male intravenous drug abuser presenting with persistent pacemaker lead thrombosis with superimposed pacemaker lead endocarditis. He underwent urgent surgery, but expired due to refractory sepsis. This case confirms that patients with pacemakers are at risk of developing pacemaker lead thrombosis. In addition, they are at high risk of developing pacemaker lead endocarditis if additional risk factors for endocarditis are present. We believe this case report is unusual on account of pacemaker lead thrombosis as well as endocarditis occurring in a patient with history of intravenous drug abuse. Whether pacemaker patients with multiple leads need to be on long-term antiplatelet or anticoagulation therapy necessitates further studies.
No takes yet. Share an insight, caveat, or question.
Panduranga et al. (2011) conducted a case report in Pacemaker lead thrombo-endocarditis (n=1). Intravenous drug abuse was evaluated on Clinical outcome. A 30-year-old male intravenous drug abuser with a pacemaker developed persistent pacemaker lead thrombosis and superimposed endocarditis, ultimately expiring due to refractory sepsis.
Synapse has enriched 10 related papers. Consider them for comparative context: